http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114306350-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2023-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2023-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114306350-B |
| titleOfInvention | Use of cholesterol sulfate in the preparation of medicines for the prevention of sepsis |
| abstract | The invention provides the use of cholesterol sulfate in the preparation of medicines for preventing sepsis. The present invention proves through animal experiments that sodium cholesterol sulfate can effectively prevent sepsis and its complications, protect the liver, kidneys, lungs, and heart, and significantly reduce the main inflammation of TNF-α and IL-6 in the serum of septic mice The level of factor, thereby exerting obvious protective effect on the body, injection of the cholesterol sulfate sodium salt can significantly improve the survival rate and survival time of sepsis mice. On the whole, the cholesteryl sulfate ester salt involved in the present invention has a good application prospect in the prevention of sepsis. |
| priorityDate | 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.